Project M

Evidence-based Care Strategy Optimization Platform

Health Tech & Life Sciences
Private

Company Overview

Snapshot

Founded in May 2023 by Ahuva Meilik, Project M operates with 1–10 employees. The company is currently in the Pre-Funding stage, focusing on optimizing care strategies within inpatient settings. In May 2026, Project M was featured in Globes' 20th annual promising startup project, inviting public ranking for the "audience favorite" startup.

Business overview

Project M develops an evidence-based care strategy optimization platform for inpatient settings, leveraging proprietary technology that incorporates AI and causal inference AI models. The company's core product delivers real-time, individualized care strategy optimizations by analyzing patient similarities, aiming to improve outcomes while minimizing costs. Project M serves the healthcare industry, specifically targeting providers within the Health Tech & Life Sciences sector, with a focus on Digital Healthcare and Medical Decision Support.

Strategic signal

In May 2026, Project M was highlighted in Globes' 20th annual promising startup project, which invited public participation to rank the "audience favorite" startup. This recognition signals growing visibility and market interest in Project M's innovative approach to healthcare optimization, suggesting potential for future partnerships and investment as it gains public and industry validation.

Company Intelligence Q&A

When was Project M founded?
Project M was founded in May 2023.
Who is the founder of Project M?
Ahuva Meilik is the Founder & CEO of Project M.
What is Project M's primary focus?
Project M focuses on reducing economic and clinical variation in inpatient settings by optimizing care strategies using AI and causal inference AI models.
What recent recognition did Project M receive?
In May 2026, Project M was featured in Globes' 20th annual promising startup project, which included a public ranking for the "audience favorite" startup.